Orion Investment CO Blueprint Medicines Corp Transaction History
Orion Investment CO
- $251 Billion
- Q4 2024
A detailed history of Orion Investment CO transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Orion Investment CO holds 108,670 shares of BPMC stock, worth $9.47 Million. This represents 3.78% of its overall portfolio holdings.
Number of Shares
108,670
Previous 108,610
0.06%
Holding current value
$9.47 Million
Previous $10 Billion
5.66%
% of portfolio
3.78%
Previous 3.91%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$590 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$579 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$495 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$373 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$218 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.2B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...